Clinical Trials Browser

INDUSTRY × Pemetrexed × Other solid neoplasm × Clear all

Mesothelioma, Malignant, Mesothelioma

Advanced Solid Tumors

Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumour

Advanced Solid Tumor Cancer

Mesothelioma, Malignant

Advanced Solid Tumors

Advanced Solid Tumor

Advanced Solid Tumors

Advanced KRAS G12D Mutant Solid Tumors

Advanced Solid Tumor

Locally Advanced and Metastatic Solid Tumors

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma

Mesothelioma

Mesothelioma, Malignant, Mesothelioma

Advanced Solid Tumor

Mesothelioma, Malignant

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

Mesothelioma, Malignant

Mesothelioma, Malignant, Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Severe combined immunodeficiency with sensitivity to ionizing radiation, Mesothelioma, Malignant

Lung Neoplasms, Mesothelioma

Mesothelioma

Mesothelioma, Malignant

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mesothelioma

Mesothelioma, Malignant

Mesothelioma

Mesothelioma

Mesothelioma

Clinical Trials

eVOLVE-Meso

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

KANDLELIT-001

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

CheckMate 6DW

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

MICA

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

CVL006-T1002

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

MK-3475-A17

CheckMate743

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

ATOMIC

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Amatuximab

A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

A Study of LY3023414 in Participants With Advanced Cancer

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

ARTEMIS

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Nintedanib (BIBF 1120) in Mesothelioma

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma